Jefferies Group's PFE Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 1.23 M shares of Pfizer Inc. (PFE) worth $30.63 M, representing 0.16% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in PFE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 837,581 shares. Largest reduction occurred in Q1 2025, reducing 947,800 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Pfizer (PFE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Pfizer (PFE) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +837,581 | Add 213.29% | 1.23 M | $24.90 |
| Q3 2025 | +139,316 | Add 54.98% | 392,700 | $25.48 |
| Q2 2025 | -129,721 | Reduce 33.86% | 253,384 | $24.24 |
| Q1 2025 | -947,800 | Reduce 71.21% | 383,105 | $25.34 |
| Q4 2024 | +813,374 | Add 157.16% | 1.33 M | $26.53 |
| Q3 2024 | -694,330 | Reduce 57.29% | 517,531 | $28.94 |
| Q2 2024 | +746,856 | Add 160.61% | 1.21 M | $27.98 |
| Q1 2024 | +194,545 | Add 71.93% | 465,005 | $27.75 |
| Q4 2023 | +150,214 | Add 124.92% | 270,460 | $28.79 |
| Q3 2023 | +15,815 | Add 15.14% | 120,246 | $33.17 |
| Q2 2023 | +36,528 | Add 53.79% | 104,431 | $36.68 |
| Q1 2023 | -155,733 | Reduce 69.64% | 67,903 | $40.80 |
| Q4 2022 | +223,636 | New Buy | 223,636 | $51.24 |
Jefferies Group's Pfizer Investment FAQs
Jefferies Group first purchased Pfizer Inc. (PFE) in Q4 2022, acquiring 223,636 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Pfizer Inc. (PFE) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to Pfizer Inc. (PFE) was in Q4 2025, adding 1,230,281 shares worth $30.63 M.
According to the latest 13F filing for Q4 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 1,230,281 shares of Pfizer Inc. (PFE), valued at approximately $30.63 M.
As of the Q4 2025 filing, Pfizer Inc. (PFE) represents approximately 0.16% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Pfizer Inc. (PFE) was 1,330,905 shares, as reported at the end of Q4 2024.